Early prediction of adult lymphoma-associated haemophagocytic lymphohistiocytosis using an interpretable machine learning model
Machine learning model flags a dangerous lymphoma complication hours earlier using routine blood tests, giving doctors critical time for treatment.
This study developed and validated an interpretable random forest model to differentiate lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH) — a high-mortality lymphoma complication — from other HLH subtypes early using routine CBC and lab parameters. Achieving AUC 0.794 on validation, the model was deployed as a web tool to facilitate prompt targeted treatment.
What the study was
- Study design
- Retrospective cohort with ML model development and validation
- Population
- Adult patients with HLH (LA-HLH n=126, non-LA-HLH n=254)
- Sample size
- 380
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- British Journal of Haematology
Why it surfaced
ML diagnostic tool using routine CBC/lab parameters for a high-mortality hematologic complication; validated cohort, deployed as web tool — directly actionable in clinical hematology practice. Hits triage_score ≥ 8 threshold.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.